The articles say's: “Many medical journals are becoming marketing instruments for the drug companies," Sidney Wolfe, M.D., Director of Public Citizen's Health Research Group, said.
A new study finds 2 percent of scientists admit they have fabricated, falsified or altered data to improve the outcome at least once. About 35 percent admit to questionable research practices. A JAMA study reveals that 30 percent of the original research studied was either false or exaggerated. Problems include small study size, design flaws, publication bias and failure to publish negative results.
"A smart drug company -- maybe not an ethical one, but a smart one -- might decide to publish only those studies that put its drug or device in the best light," Dr. Lurie said."
But what can be done to protect patients/consumers? Some momentum is being gained to establish a data base were the results of all clinical trials, negative and positive results, can be queried.
We have posted many articles on this subject, which makes a strong case against preemption.
Knowing what we now know, can we afford to not do anything? I think not.
Any plan to overhaul our health care system has got to include a critical assessment of the FDA, medical associations and their guidelines including the guidelines for publishing clinical trial results.
We need to restore credibility and trust in our health care system.